Edition:
United States

Biomerica Inc (BMRA.OQ)

BMRA.OQ on NASDAQ Stock Exchange Capital Market

3.95USD
3:59pm EST
Change (% chg)

$0.03 (+0.77%)
Prev Close
$3.92
Open
$3.90
Day's High
$3.99
Day's Low
$3.90
Volume
2,937
Avg. Vol
1,921
52-wk High
$4.10
52-wk Low
$1.92

Latest Key Developments (Source: Significant Developments)

Biomerica extends license agreement with Celtis Pharm
Tuesday, 7 Nov 2017 08:19am EST 

Nov 7 (Reuters) - Biomerica Inc ::Biomerica extends exclusive license agreement with Celtis Pharm (Telcon Pharmaceuticals) to December 2019.Biomerica Inc - has extended its exclusive license agreement with Celtis Pharm Co. Ltd of South Korea​.Biomerica - ‍term of exclusivity agreement is five years with an additional two years for telcon to receive Korean FDA clearance​.Biomerica - agreement may be cancelled if co has not obtained final clearance for sale of products in U.S. from FDA on or before December 31, 2019​.  Full Article

Biomerica Inc Q1 ‍net sales $1.4 million
Tuesday, 17 Oct 2017 08:19am EDT 

Oct 17 (Reuters) - Biomerica Inc :Net sales of $1.4 million for three months ending August 31, 2017, an increase of 2.4%​.Net loss for three months ended August 31, 2017 was $207,059 compared to a net loss of $55,417 during same period in fiscal 2017​.  Full Article

Biomerica announces point of care product distribution agreement with a multinational pharmaceutical company
Wednesday, 16 Aug 2017 08:19am EDT 

Aug 16 (Reuters) - Biomerica Inc :Biomerica announces point of care product distribution agreement with a multinational pharmaceutical company.Biomerica Inc - ‍distribution agreement to supply one of point of care products to a multinational pharmaceutical company for distribution in Mexico​.Biomerica inc - specific terms of distribution agreement were not disclosed and will remain confidential.  Full Article

Biomerica files for stock shelf of up to $45 mln
Friday, 30 Jun 2017 05:41pm EDT 

June 30 (Reuters) - Biomerica Inc ::Biomerica Inc files for stock shelf of up to $45 million - SEC filing.  Full Article

Biomerica reports Q3 net loss of $304,141
Monday, 17 Apr 2017 08:19am EDT 

April 17 (Reuters) - Biomerica Inc :Biomerica announces third quarter financial results, sales up 13.9 pct for nine months.Q3 sales $1.5 million versus $1.362 million.Net loss for 3 months ended February 28, 2017 was $304,141 compared to a net loss of $135,002 during three months ended February 29, 2016.  Full Article

Xiamen Red Phase Instruments sees Q1 FY 2017 net loss to be 5 mln yuan to 6.5 mln yuan
Thursday, 23 Mar 2017 01:59am EDT 

Xiamen Red Phase Instruments Inc <300427.SZ> : Sees Q1 FY 2017 net loss to be 5 million yuan to 6.5 million yuan . Says Q1 FY 2016 net loss was 5.8 million yuan .The reason for the forecast is seasonal effect.  Full Article

Biomerica Q2 loss per share $0.02
Wednesday, 18 Jan 2017 08:19am EST 

Biomerica Inc : Biomerica announces second quarter financial results; sales up over 22% for the quarter . Q2 loss per share $0.02 . Q2 sales rose 22.9 percent to $1.432 million ."Our Asia sales continued to increase in Q2 while sales in Europe were relatively flat".  Full Article

BRIEF-Biomerica Enters Into At Market Issuance Sales Agreement With B. Riley FBR

* BIOMERICA INC - ‍ON DEC. 1, 2017, CO ENTERED INTO AN AT MARKET ISSUANCE SALES AGREEMENT WITH B. RILEY FBR, INC - SEC FILING​